These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacological treatment of Raynaud's phenomenon with special reference to calcium-entry blockers. Nilsson H Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():137-49. PubMed ID: 2872769 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Raynaud's phenomenon. Wollersheim H; van Zwieten PA Eur Heart J; 1993 Feb; 14(2):147-9. PubMed ID: 8095453 [No Abstract] [Full Text] [Related]
4. Raynaud's phenomenon. Grisanti JM Am Fam Physician; 1990 Jan; 41(1):134-42. PubMed ID: 1967198 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of Raynaud's phenomenon]. Lazareth I Ann Dermatol Venereol; 1987; 114(8):1035-8. PubMed ID: 2892456 [No Abstract] [Full Text] [Related]
6. [An update on the management of Raynaud's phenomenon]. Rodríguez-García JL An Med Interna; 1991 Oct; 8(10):513-20. PubMed ID: 1751694 [TBL] [Abstract][Full Text] [Related]